169 related articles for article (PubMed ID: 16789756)
21. Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3).
Fujita Y; Tsuda Y; Motoyama T; Li T; Miyazaki A; Yokoi T; Sasaki Y; Ambo A; Niizuma H; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
Bioorg Med Chem Lett; 2005 Feb; 15(3):599-602. PubMed ID: 15664820
[TBL] [Abstract][Full Text] [Related]
22. Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixed μ/δ opioid receptor agonistic properties.
Vandormael B; Fourla DD; Gramowski-Voss A; Kosson P; Weiss DG; Schröder OH; Lipkowski A; Georgoussi Z; Tourwé D
J Med Chem; 2011 Nov; 54(22):7848-59. PubMed ID: 21978284
[TBL] [Abstract][Full Text] [Related]
23. Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists.
Li T; Jinsmaa Y; Nedachi M; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Bryant SD; Marczak E; Li Q; Swartzwelder HS; Lazarus LH; Okada Y
Bioorg Med Chem; 2007 Feb; 15(3):1237-51. PubMed ID: 17142049
[TBL] [Abstract][Full Text] [Related]
24. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
[TBL] [Abstract][Full Text] [Related]
25. 2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.
Sasaki Y; Sasaki A; Ariizumi T; Igari Y; Sato K; Kohara H; Niizuma H; Ambo A
Biol Pharm Bull; 2004 Feb; 27(2):244-7. PubMed ID: 14758045
[TBL] [Abstract][Full Text] [Related]
26. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
[TBL] [Abstract][Full Text] [Related]
27. Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).
Balboni G; Guerrini R; Salvadori S; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2005 Dec; 48(26):8112-4. PubMed ID: 16366592
[TBL] [Abstract][Full Text] [Related]
28. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
Elliott J; Traynor JR
Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
[TBL] [Abstract][Full Text] [Related]
29. Chemical space screening around Phe
Willemse T; Eiselt E; Hollanders K; Schepens W; van Vlijmen HWT; Chung NN; Blais V; Holleran B; Longpré JM; Schiller PW; Maes BUW; Sarret P; Gendron L; Ballet S
Bioorg Med Chem Lett; 2018 Jul; 28(13):2320-2323. PubMed ID: 29853330
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
Giri AK; Apostol CR; Wang Y; Forte BL; Largent-Milnes TM; Davis P; Rankin D; Molnar G; Olson KM; Porreca F; Vanderah TW; Hruby VJ
J Med Chem; 2015 Nov; 58(21):8573-83. PubMed ID: 26465170
[TBL] [Abstract][Full Text] [Related]
32. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
33. Assessment of substitution in the second pharmacophore of Dmt-Tic analogues.
Santagada V; Balboni G; Caliendo G; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Lazarus LH
Bioorg Med Chem Lett; 2000 Dec; 10(24):2745-8. PubMed ID: 11133082
[TBL] [Abstract][Full Text] [Related]
34. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S
Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105
[TBL] [Abstract][Full Text] [Related]
35. Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.
Ballet S; Marczak ED; Feytens D; Salvadori S; Sasaki Y; Abell AD; Lazarus LH; Balboni G; Tourwé D
Bioorg Med Chem Lett; 2010 Mar; 20(5):1610-3. PubMed ID: 20137938
[TBL] [Abstract][Full Text] [Related]
36. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
38. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
[TBL] [Abstract][Full Text] [Related]
39. New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif.
Li T; Shiotani K; Miyazaki A; Fujita Y; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Lazarus LH; Okada Y
Bioorg Med Chem Lett; 2005 Dec; 15(24):5517-20. PubMed ID: 16183273
[TBL] [Abstract][Full Text] [Related]
40. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.
McConalogue K; Grady EF; Minnis J; Balestra B; Tonini M; Brecha NC; Bunnett NW; Sternini C
Neuroscience; 1999 Mar; 90(3):1051-9. PubMed ID: 10218804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
